Novo Nordisk CEO's pay sets itself apart on especially one point
German investment bank Berenberg has compared the salaries of a range of top execs in the pharmaceutical industry, and in opposition to everyone else, Lars Fruergaard Jørgensen's bonus scheme is not tied to the company share price.
BY BENJAMIN WERNER CHRISTENSEN, TRANSLATED BY NIELSINE NIELSEN
The bonus scheme of Novo Nordisk CEO and President Lars Fruergaard Jørgensen is not tied in with the share price of the Danish pharmaceutical company, which comes as a surprise to German investment bank Berenberg.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
